Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone safely and effectively treats hair loss in female scarring alopecia patients.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Dermatoscopy is useful for identifying different hair and scalp conditions and can reduce the need for biopsies.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Scalp dermoscopy is good for diagnosing a type of hair loss and helps choose the best spots for biopsy.

No single treatment is consistently effective for alopecia areata, and more research is needed.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Treating psoriasis on the scalp, nails, and skin folds is challenging, often requiring systemic treatments for severe cases, with some success in topical and biologic treatments.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

The conclusion is that an algorithm using trichoscopy helps diagnose different types of hair loss but may need updates and a biopsy if results are unclear.

Minoxidil can help regrow hair in alopecia areata patients.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Stress increases certain chemicals in the skin and nerves, which might worsen skin conditions.

Children with atopic dermatitis often have sleep problems due to itching and may benefit from melatonin, which helps with sleep and skin symptoms.

Higher minoxidil concentration (5%) works better for severe hair loss, with most patients seeing regrowth in 48-60 weeks.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

Hair microRNAs could be effective biomarkers for diagnosing scleroderma.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Trichoscopy is a useful tool for diagnosing hair and scalp issues, but doctors must be careful to avoid mistakes.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Cholesterol-related compounds can stop hair growth and cause inflammation in a type of scarring hair loss.

Different techniques for vitiligo treatment work similarly well, with some better for specific body areas.

Non-immune factors play a significant role in alopecia areata.

A young woman with a rare hair loss condition improved with steroid and biotin treatment.